Journal Article

The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003

Anthony F. Lehman, Julie Kreyenbuhl, Robert W. Buchanan, Faith B. Dickerson, Lisa B. Dixon, Richard Goldberg, Lisa D. Green-Paden, Wendy N. Tenhula, Daniela Boerescu, Cenk Tek, Neil Sandson and Donald M. Steinwachs

in Schizophrenia Bulletin

Published on behalf of Maryland Psychiatric Research Center

Volume 30, issue 2, pages 193-217
Published in print January 2004 | ISSN: 0586-7614
Published online January 2004 | e-ISSN: 1745-1701 | DOI: http://dx.doi.org/10.1093/oxfordjournals.schbul.a007071
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003

More Like This

Show all results sharing this subject:

  • Child and Adolescent Psychiatry

GO

Show Summary Details

Preview

Since publication of the original Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations in 1998, considerable scientific advances have occurred in our knowledge about how to help persons with schizophrenia. Today an even stronger body of research supports the scientific basis of treatment. This evidence, taken in its entirety, points to the value of treatment approaches combining medications with psychosocial treatments, including psychological interventions, family interventions, supported employment, assertive community treatment, and skills training. The most significant advances lie in the increased options for pharmacotherapy, with the introduction of second generation antipsychotic medications, and greater confidence and specificity in the application of psychosocial interventions. Currently available treatment technologies, when appropriately applied and accessible, should provide most patients with significant relief from psychotic symptoms and improved opportunities to lead more fulfilling lives in the community. Nonetheless, major challenges remain, including the need for (1) better knowledge about the underlying etiologies of the neurocognitive impairments and deficit symptoms that account for much of the disability still associated with schizophrenia; (2) treatments that more directly address functional impairments and that promote recovery; and (3) approaches that facilitate access to scientifically based treatments for patients, the vast majority of whom currently do not have such access.

Keywords: Schizophrenia; mental health services; quality of care; treatment outcomes; pharmacotherapy; psychosocial treatment

Journal Article.  0 words. 

Subjects: Child and Adolescent Psychiatry

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.